25/05/2021 - Health

Kindly review and provide suggestions!

Sir please given me feedback of my answer

Respected Sir/Ma'am

Kindly review my answer. 

Thanking you, 

KEY POINTS

·        Immunising a country that is home to almost one-fifth of the world’s population is certainly no easy task.

·        Across India, only a few private hospitals have the requisite inventory to vaccinate this age group. Because of scarcity of vaccines, many states have already rolled back their inoculation programs for the newly added segment.

·        CoWin and Arogya Setu Apps have furthered our vaccine inequity. It is difficult for anyone without a certain degree of technical know-how to navigate them.

·        India will have to urgently accelerate vaccine production to get over these shortcomings.

·        The Serum Institute of India currently produces 2.4 million doses a day, and Bharat Biotech will produce around two million shortly.

·        The government could invoke compulsory licensing to transfer technology from our existing manufacturers to other organisations with capacity.

·        There are a few organisations within and outside India working on intranasal and oral drop COVID-19 vaccines.

·        These projects, if successful, would be game-changers, as these highly scalable solutions are ideal for Indian conditions.

·        New viral strains are proving to be dangerous to even the younger population, including children.

·        With more mutations and future waves looming over us, recovering and rebuilding from the devastating social and economic ill effects of the virus. 

Please give ur valuable suggestions for the below answer